Drug · DIN 02502984
FIRDAPSE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 23, 2020; first marketed October 23, 2020.
- Drug Identification Number (DIN)
- 02502984
- Company (DIN owner)
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Amifampridine N07XX05
- Class
- Human
- Record last updated
- June 10, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMIFAMPRIDINE (AMIFAMPRIDINE PHOSPHATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 24, 2020: NOC 24296New Drug Submission (NDS) · Change in product ownership
- July 31, 2020: NOC 23996New Drug Submission (NDS)